PharmGen Science, Inc.
PharmGen Science, Inc. (KRX: 004720) is trading at ₩2,860.00, about ₹206 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 2.05% today. PharmGen Science is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩2,810.00
Today's high
₩2,970.00
52 week low
₩2,590.00
52 week high
₩4,485.00
004720 opened at ₩2,970.00, closed previously at ₩2,920.00, and has traded between ₩2,590.00 and ₩4,485.00 over the past 52 weeks.
About
PharmGen Science, Inc., originally founded in 1961 as Wooridul Pharmaceutical Limited, is a South Korean company primarily involved in the research, development, manufacturing, and distribution of pharmaceutical products. Based in Hwaseong, South Korea, the firm offers a diverse portfolio encompassing prescription medications, over-the-counter drugs, nutritional supplements, and cosmetic items. These are available in various forms, including tablets, hard capsules, granules, ointments, syrups, and suspensions.
Key statistics
Avg. volume
67.20K
Market cap
₩62.67B
P/E Ratio
-0.47
Price-to-sales ratio
0.36
Enterprise value
₩75.34B
Free cash flow yield
4.23%
Debt-to-equity ratio
0.00
Return on equity
-79.73%
ROIC
2.76%
Beta
0.24
Dividend yield
0.00%
Last dividend
₩0.00
Financial overview
Revenue
₩173.07B
Earnings per share
-₩5,312.85
Free cash flow
₩3.86B
Net profit margin
-76.62%
Gross margin
64.26%
EBITDA
₩10.53B
Revenue growth
1.04%
Similar securities
This is not an investment recommendation
PharmGen Science for Indian investors
PharmGen Science is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on PharmGen Science for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NonePharmGen Science does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
FAQs
Can I buy PharmGen Science on Paasa?
PharmGen Science (004720) has been listed on the Korea Exchange since 2000, in the Drug Manufacturers - General industry. PharmGen Science is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one PharmGen Science share cost in rupees?
One PharmGen Science share is ₩2,860.00 — about ₹206 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the PharmGen Science price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on PharmGen Science shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the PharmGen Science price.
Does PharmGen Science pay a dividend?
No. PharmGen Science does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one: dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare PharmGen Science shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on PharmGen Science?
Yes. PharmGen Science is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.